Dose-Escalation Regimens for Incretin Mimetics in Type 2 Diabetes Are Associated With Tolerance for Nausea and Vomiting.

Diabetes Obes Metab · 2026 · PMC13071187 · PMID 41757397

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a clear trendno p-value reported

In addition, a clear trend is observed toward dose escalation occurring over a greater number of steps (overall range: 1–6), distributed across a substantially longer period of time (overall range: 0–20 weeks). 3.2.

also in 19,460 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.